Can Dose Reduction to One Parotid Gland Prevent Xerostomia? — A Feasibility Study for Locally Advanced Head and Neck Cancer Patients Treated with Intensity-modulated Radiotherapy

2006 ◽  
Vol 18 (6) ◽  
pp. 497-504 ◽  
Author(s):  
A.K. Anand ◽  
J. Jain ◽  
P.S. Negi ◽  
A.R. Chaudhoory ◽  
S.N. Sinha ◽  
...  
2015 ◽  
Vol 191 (6) ◽  
pp. 501-510 ◽  
Author(s):  
Silke Tribius ◽  
Marieclaire Raguse ◽  
Christian Voigt ◽  
Adrian Münscher ◽  
Alexander Gröbe ◽  
...  

2007 ◽  
Vol 85 (1) ◽  
pp. 36-41 ◽  
Author(s):  
Teresa Guerrero Urbano ◽  
Catharine H. Clark ◽  
Vibeke N. Hansen ◽  
Elizabeth J. Adams ◽  
Roger A’Hern ◽  
...  

2012 ◽  
Vol 3 (1) ◽  
pp. 1-4
Author(s):  
Sonal Vahanwala ◽  
Sukhjinder Kaur Khosa ◽  
Sandeep S Pagare

ABSTRACT Xerostomia is one of the most common side effects after radiation therapy for treating head and neck cancers. Our objective was to evaluate the salivary flow in patients treated with Intensity-modulated radiotherapy with two samples: (a) Resting saliva and (b) stimulated saliva. We performed three salivary sample collections: At the beginning, during and immediately after radiotherapy. The results showed that there was a significant decrease in the whole resting (11.46%) and stimulated (15.06%) salivary flow values during the first 3 weeks of the radiotherapy (p = 0.0025, p = 0.0034 respectively). How to cite this article Khosa SK, Vahanwala S, Pagare SS. Correlation of Parotid Gland Function in Head and Neck Cancer Patients treated with Intensity-modulated Radiotherapy. Int J Head and Neck Surg 2012;3(1):1-4.


Sign in / Sign up

Export Citation Format

Share Document